CML is an MPN that is characterized by the clonal proliferation of myeloid elements (predominantly granulocytes) resulting from a reciprocal translocation of the ABL gene (located on chromosome 9) and the breakpoint cluster region BCR gene (located on chromosome 22) [1,13]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.